What are the different trends in Peanut allergy treatment Market to boost its growth? | Top Key Players - Mylan, Sanofi, Pfizer, Teva Pharmaceuticals, Johnson & Johnson, DBV Technologies, Aimmune Therapeutics

Peanut allergy treatment market expected to grow with a double-digit growth rate as the expected launch of the new products in the market. These products will gain higher demand in the market as unavailability of peanut allergy treatment medicines. Peanut allergy treatment market expected to gain significant growth rate over the forecast period as increasing number of clinics visit for allergy treatment. Increasing number of research and development for the launch of immunotherapy prod-ucts expected to boost up growth opportunity for peanut allergy treatment market. Peanut allergy treatment market will spur over the forecast period as increasing investments, scientific develop-ments, and commercial activities.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/28831

Peanut allergy is the most common of childhood food allergies. Around 2.5% of children suffered from peanut allergy in the United States. Peanut allergy can cause several allergic reactions includ-ing anaphylaxis. There is no approved treatment available for the peanut allergy, only the experi-mental drugs are used for the peanut allergy treatment. But manufacturers and researcher are studying the use of the immunotherapy drugs for the of peanuts allergy treatment.

Immunotherapy drugs are not FDA approved till now. FDA is expected to approve one or more than one peanut al-lergy immunotherapy products for peanut allergy treatment. Companies such as DBV Technologies, Aimmune Therapeutics, Prota Therapeutics Pty Ltd., Camallergy are conducting clinical trials for the development of peanut allergy treatment products. DBV technologies immunotherapy product ‘Viaskin Peanut’ will be most likely to be first peanut allergy treatment product in the market. Viaskin Peanut is skin or a dermal patch containing 250 microgram of peanut protein drugs.

The global peanut allergy treatment market is segmented on basis of drug type, route of administration, distribution channel and region:

Segmentation by Drug Type

Epinephrine Injection (EpiPen, Twinject, AUVI-Q)
Antihistamines

Segmentation by Route of Administration

Oral
Injectable

Segmentation by Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stor

Some of the players operating in the global peanut allergy treatment market are Mylan Inc., Sanofi SA, Pfizer Inc., kaleo, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Inc., DBV Technologies, Aimmune Therapeutics, Prota Therapeutics Pty Ltd., and others.

Recently only symptomatic treatment drugs are available for the treatment of the peanut allergy treatment. Epinephrine injection and antihistamines are the most commonly prescribed drugs for relief from allergy. Peanut allergy is one of the most common food allergies in adults and children. Peanut allergy causes several allergic reactions. Peanut allergy is the leading cause of death due to food allergy. The prevalence of peanut allergy is higher in western countries and the highest among children. Peanut allergy has associated with several allergic conditions such as asthma, atopic dermatitis, and fever. Several clinical trials are ongoing for approval of immunotherapy and desensitization products but currently not available for clinical use. Based on the distribution channel, the peanut allergy treatment market is segmented into hospital pharmacies, online pharmacies, online pharmacies, and retail pharmacies. Hospital pharmacies are expected to gain a high share in the peanut allergy treatment market as the accessibility for the patient and medical staff.

Request For TOC @ https://www.persistencemarketresearch.com/toc/28831

Regionally, the global peanut allergy treatment market is segmented into five key regions viz. North America, Latin America, Europe, Middle East & Africa and the Asia Pacific. North America is ex-pected to contribute a major revenue share in the global peanut allergy treatment market owing to the high prevalence of peanut allergy. North America and Europe expected to gain most of the share in the peanut allergy treatment market as increasing prevalence of peanut allergy in western countries. Peanut allergy treatment market in the Asia-Pacific region is expected to witness signifi-cant growth rate in the coming years due to the growing number of allergy testing and increasing healthcare spending.
The report covers exhaustive analysis on:

Peanut Allergy Treatment Market Segments
Peanut Allergy Treatment Market Dynamics
Historical Actual Market Size, 2013 - 2017
Peanut Allergy Treatment Market Size & Forecast 2018 to 2026
Peanut Allergy Treatment Market Current Trends/Issues/Challenges
Competition & Companies involved
Peanut Allergy Treatment Market Drivers and Restraints

Regional Analysis:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Report Highlights:

Shifting industry dynamics
In-depth market segmentation
Historical, current and projected industry size recent industry trends
Key competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Get Full Report@ https://www.persistencemarketresearch.com/market-research/peanut-allergy-treatment-market.asp

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.